Skip to content
Rime Bioinformatics logo — Making high performance bioinformatics accessible.

Rime Bioinformatics

Making high performance bioinformatics accessible.

Founded 2021 France France 5 employees Non Equity Assistance Biotechnology, Clean Energy

General Information

Company Name Rime Bioinformatics
Founded Year 2021
Location France France
Employees 5
Industries Biotechnology, Clean Energy
Funding Stage Non Equity Assistance
Business Model B2B, SaaS, DaaS
Revenue Model Service Fee, Usage Based, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Rime Bioinformatics. To contact Rime Bioinformatics, visit rime-bioinformatics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rime Bioinformatics compare?

A PDF of Rime Bioinformatics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rime Bioinformatics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rime Bioinformatics

Rime Bioinformatics, founded in 2021, is a research and development biotechnology company headquartered in France. Specializing in bioinformatics, their slogan, "Making high performance bioinformatics accessible," underscores their mission to democratize cutting-edge bioinformatics.

The company focuses on expediting research in medical, agronomic, and veterinary fields. Their services provide comprehensive insights into bacterial and bacteriophage genomes, a critical step for advancing phage therapy in the market. This focus aligns well with the industry's increasing emphasis on sustainable and safe therapeutic solutions.

Positioned at the intersection of Biotechnology and Clean Energy, Rime Bioinformatics benefits from the supportive backing of AGORANOV, which provided non-equity assistance in June 2022. As it seeks to expand its influence in bioinformatics and phage therapy, Rime Bioinformatics is poised for growth in dynamic and environmentally conscious sectors.

Business keywords: Bioinformatics, Phage Therapy, Bacteriophage Genomics, Metagenomics, R&D in Biotechnology, Medical Research Acceleration, Agronomic Research, Veterinary Research, Bacterial Genomes, Genome Analysis, Bioinformatics Accessibility, Environmental Safety in Phage Therapy, Biotech Innovation

Services & Products

High-performance Bioinformatics Analysis
Phage Therapy Analysis
DNA/RNA Sequencing Data Analysis
Development of Analysis Methods for Phage Genomes

Target Customers

Biologists Medical Researchers Agronomy Experts Veterinary Researchers Pharmaceutical Companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
AGORANOV
01 Jun 2022

Rime Bioinformatics Alternatives & Competitors

View All Alternatives
Rime Bioinformatics vs
DNAnexus
DNAnexus United States

The Global Standard for Omics Intelligence

274 employees
Biotechnology, Computing
Rime Bioinformatics vs
Macrogen Europe
Macrogen Europe The Netherlands

Committed to Sequencing Excellence

71 employees
Biotechnology, Health Care
Rime Bioinformatics vs
Parse Biosciences
Parse Biosciences United States

Scalable Single Cell Sequencing Without the Instrument

Acquired
148 employees
Biotechnology, Life Sciences

FAQ About Rime Bioinformatics

Making high performance bioinformatics accessible.
Rime Bioinformatics was founded in 2021.
Rime Bioinformatics is headquartered in France.
Rime Bioinformatics operates in Biotechnology and Clean Energy. Its work centres on Bioinformatics, Phage Therapy, Bacteriophage Genomics and Metagenomics. Its customers include Biologists, Medical Researchers and Agronomy Experts.
Rime Bioinformatics has a B2B, SaaS and DaaS business model. Its revenue comes from Service Fee, Usage Based and Subscription.
Rime Bioinformatics has approximately 5 employees.
Rime Bioinformatics has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Rime Bioinformatics offers: High-performance Bioinformatics Analysis, Phage Therapy Analysis, DNA/RNA Sequencing Data Analysis, Development of Analysis Methods for Phage Genomes.
Top alternatives and competitors to Rime Bioinformatics include DNAnexus, Macrogen Europe, Parse Biosciences, GOENOMICS GmbH, Xegen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rime Bioinformatics and DNAnexus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rime Bioinformatics, https://bouncewatch.com/company/rime-bioinformatics, updated 23 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout